HUMAN GENOME SCIENCES (NASDAQ: HGSI)

View Portfolio
Back to Investopedia
Back to Investopedia




$26.67 0.91 (3.53%)
Real-time 12:00:00 AM ET
 Turn On
KEY STATS
52-Week High Price
32.07
52-Week Low Price
0.45
Avg Volume (3 Mo.)
3.00 M
Market Cap
4.41 B
P/E Ratio (TTM)
0.0
Diluted EPS (TTM)
-0.03
Shares
165.01 M
Dividend Rate ($) / (%)
0.00/0.00
92%
8%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 958% - HGSI has outperformed the S&P 500 by 932%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
WARNER CHILCOTT A (WCRX) $25.56 -  $0.35(1.39%)6.42 B
SIGMA-ALDRICH CORP (SIAL) $48.07 -  $1.28(2.74%)5.78 B
MYLAN INC (MYL) $17.80 -  $0.04(0.24%)5.47 B
CEPHALON INC (CEPH) $65.58 -  $0.58(0.89%)4.81 B
QIAGEN NV (QGEN) $20.70 -  $0.04(0.19%)4.81 B
ALEXION PHARMACEUTICALS (ALXN) $46.68 -  $0.71(1.54%)4.14 B
PERRIGO CO (PRGO) $46.34 -  $0.60(1.31%)4.13 B
DR REDDY'S LAB LTD ADS (RDY) $23.37 -  $0.03(0.13%)4.07 B
WATSON PHARMACEUTICALS (WPI) $38.10 -  $0.41(1.09%)4.05 B
ELAN CORP PLC (ELN) $7.00 -  $0.03(0.43%)3.37 B
As of February 09, 2010 at 12:00 PM ET
STOCK ANALYSIS
Stock Analysis
A Review Of The Drug Makers Of 2009 (PFE, MRK, BMY)
Corporate deal-making was the name of the big pharma game in 2009 and will likely continue into the new year.
Stock Analysis
Will Technicals Destroy Market Rally? (HGSI, PALM, CRR, SCHN)
The market rally has been strongly questioned as an illegitimate move lacking in fundamentals.
Stock Analysis
Four High-Flying Pharmaceutical Companies (GSK, VNDA, BCRX, OGXI, HGSI, NVS)
A look at some of the best-performing stocks year to date - up anywhere from 400% to 2000%.
Stock Analysis
"Sell In May And Go Away" Not Working This Year (ITB, XHB, FAS, HGSI, RDN)
The old Wall Street saying of "Sell in May and Go Away" is not working out, as investors who followed this cliche h...
Stock Analysis
Vertex Needs A Relaxation Shot (VRTX)
Vertex has seen some great volatility this year. Will the volatility continue?
View All Stock Analysis
HGSI RELATED HEADLINES
arrow
Human Genome Sciences (HGSI) Flooded by Front-Month Activity
Front-month call traders have flocked to Human Genome Sciences (HGSI: sentiment, chart, options) today, with intraday volume soaring to abnormally lofty levels...(Read More)
By SchaeffersResearch 2/5/2010
arrow
Human Genome Sciences (HGSI) NewsBite - HGSI Gets Outperform Rating From RBC
Human Genome Sciences (NASDAQ: HGSI) opened at $27.92. So far today, the stock has hit a low of $27.41 and a high of $27.95. HGSI is now trading at $27.67, up $0.15 (0.55%). Over the last 52 weeks the stock has ranged from a low of $.45 to a high of $32.07. HGSI shares are rising today after analysts at RBC Capital Markets initiated coverage on the stock, starting it...
At Market Intelligence Center 1/27/2010
arrow
Doubts Build On Glaxo's Antiaging Drugs
The drugmaker bet $720 million on drugs based on the wine-ingredient resveratrol. New studies suggest that the drugs won't work.
Forbes.com 1/26/2010
arrow
The Lupus Drug Gold Mine
After decades of dead ends scientists find new treatments.
Forbes.com 1/22/2010
arrow
A Review Of The Drug Makers Of 2009 (PFE, MRK, BMY)
Corporate deal-making was the name of the big pharma game in 2009 and will likely continue into the new year.
at Investopedia Advisor 12/29/2009
arrow
Human Genome Sciences (HGSI) NewsBite - HGSI Hits 52-Week High
Human Genome Sciences (NASDAQ: HGSI) hit a new 52-Week high of $29.98 so far today. Morgan Stanley analysts initiated the stock at Overweight today. Currently the stock is up $1.17 (4.15%) to $29.34 on 5,976,739 shares traded. Today's high is up $28.89 from a 52-Week Low of $.45. Human Genome Sciences stock has been showing support around $27.08 and resist...
At Market Intelligence Center 12/21/2009
View All Headlines
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM2